Results 241 to 250 of about 271,582 (269)
Some of the next articles are maybe not open access.

Pancreatic Neuroendocrine Tumors

Surgical Pathology Clinics, 2016
Pancreatic neuroendocrine neoplasms include well-differentiated pancreatic neuroendocrine tumors (PanNETs) and neuroendocrine carcinomas (NECs) with well-differentiated PanNETs accounting for most cases. Other pancreatic primaries and metastatic carcinomas from other sites can mimic pancreatic neuroendocrine neoplasms.
Safia N. Salaria, Chanjuan Shi
openaire   +5 more sources

Tumor lysis pancreatitis

Medical and Pediatric Oncology, 1979
AbstractRapid tumor lysis may produce acute complications including systemic metabolic disturbances and hemorrhage in sites involved by tumor. We have observed two cases of acute pancreatitis induced by the lysis of lymphoma that involved the pancreas. This previously unreported cause of pancreatitis must be added to the list of potential complications
Ian T. Magrath, Robert J. Spiegel
openaire   +3 more sources

Pancreatic hepatocellular tumor

Pancreatology, 2005
Hepatocellular differentiation of pancreatic cells has been observed under certain conditions in several species, including humans. Their cell of origin and biology has remained controversial. Generally, these lesions have been considered a degenerative process.
Fumiaki Nozawa, Parviz M. Pour
openaire   +3 more sources

Pancreatic neuroendocrine tumors

Current Problems in Surgery, 2013
Pancreatic neuroendocrine tumors (PNETs) have an incidence of approximately 1 per 100,000 individuals per year, and account for 1–2% of all pancreatic tumors. The annual incidence in the United States is about 3.65 per 100,000 population. Although they may manifest at any age, they most often occur in the fourth to sixth decades of life. Most PNETs are
Geoffrey W. Krampitz, Jeffrey A. Norton
openaire   +6 more sources

Pancreatic Endocrine Tumors

Pathology - Research and Practice, 1988
In this review the current state of our understanding of endocrine tumors of the pancreas is considered. It is based on the experience with a series of 365 tumors. The first part of the article focuses on origin and classification, markers, frequency, criteria of malignancy as well as general structural features of the pancreatic endocrine tumors.
Günter Klöppel, Philipp U. Heitz
openaire   +3 more sources

Pancreatic tumors in children

Pediatric Surgery International, 1996
Pancreatic tumors rarely present in childhood. Diagnostic difficulty and inappropriate treatment may occur due to the variable clinical appearance of the illness. A 26-year audit (1968-1994) at this institution showed five patients ranging in age from 5 to 14 years who were operated upon for pancreatic tumors, four of which were malignant. In two cases
Piotr Wojciechowski   +3 more
openaire   +3 more sources

Pancreatic Tumor Microenvironment

2020
The pancreatic ductal adenocarcinoma (PDAC) microenvironment is a diverse and complex milieu of immune, stromal, and tumor cells and is characterized by a dense stroma, which mediates the interaction between the tumor and the immune system within the tumor microenvironment (TME).
Kai Wang, Hong He
openaire   +3 more sources

Cystic Pancreatic Tumors

2012
Cystic lesions of the pancreas are increasingly being recognized due to the widespread use of cross-sectional imaging, and include a large variety of lesions with different etiology and biology, each requiring a different management strategy [1]–[5].
D'Onofrio M   +2 more
openaire   +4 more sources

Pancreatic neuroendocrine tumors

Indian Journal of Gastroenterology, 2012
Pancreatic neuroendocrine tumors (pancreatic NETs) are rare, low- to intermediate-grade neoplasms thought to arise from the pancreatic islets. Recent advances in pathology and our understanding of the biological behavior of this group of tumors has resulted in changes in their nomenclature and how we treat them.
Shailesh V. Shrikhande   +3 more
openaire   +3 more sources

Pancreatic Tumors

2013
Section III - Pancreatic DuctsCap ...
MANFREDI, Riccardo   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy